Concepedia

Treatment Sequence Comparators

Treatment Sequence Comparator is a methodological framework within comparative effectiveness research that systematically evaluates the impact of different chronological orders of therapeutic interventions on clinical outcomes to determine optimal treatment pathways.

37

Publications

2.5K

Citations

383

Authors

157

Institutions

Publications per year

2017–2026

15

Parents

Publications

37

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

Kristin Kaasen Jørgensen, Inge Christoffer Olsen, Guro Løvik Goll et al. · The Lancet · 2017 · 806 citations

, , +11

The Advanced Glaucoma Intervention Study, 8: Risk of Cataract Formation After Trabeculectomy

Archives of Ophthalmology · 2001 · 250 citations · Full text

, , +17

Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide

Wolfgang Wick, Patrick Roth, Christian Hartmann et al. · Neuro-Oncology · 2016 · 228 citations · Full text

, , +17

Effect of treatment sequence in combined intrastromal corneal rings and corneal collagen crosslinking for keratoconus

Efekan Coşkunseven, Mirko Jankov, Farhad Hafezi et al. · Journal of Cataract & Refractive Surgery · 2009 · 178 citations · Full text

, , +15

Levodopa‐entacapone‐carbidopa intestinal gel in Parkinson's disease: A randomized crossover study

Marina Senek, Elisabet I. Nielsen, Dag Nyholm · Movement Disorders · 2016 · 113 citations

, , +16

1–5 of 37

Authors

383

  1. AV
    Anna Vaqué

    Esteve (Spain), Spain

    2 publications · 73 citations

    2

    h-index

  2. GE
    Gregorio Encina

    Esteve Química (Spain), Spain

    2 publications · 73 citations

    2

    h-index

  3. MS
    Mariano Sust

    Esteve Química (Spain), Spain

    2 publications · 73 citations

    2

    h-index

  4. CR
    Carlos R. Plata‐Saláman

    University of Delaware, United States

    2 publications · 73 citations

    2

    h-index

  5. LS
    Lluís Soler

    BioPhage Pharma (Canada), Canada

    2 publications · 73 citations

    2

    h-index

1–5 of 383

Institutions

157

  1. Eli Lilly (United States)

    Indianapolis, United States

    3 h-index

    6 publications

    211 citations

  2. Heinrich Heine University Düsseldorf

    Düsseldorf, Germany

    2 h-index

    32 publications

    5.8K citations

  3. Université Laval

    Québec, Canada

    2 h-index

    10 publications

    152 citations

  4. BioPhage Pharma (Canada)

    Montreal, Canada

    2 h-index

    4 publications

    146 citations

  5. The University of Melbourne

    Melbourne, Australia

    2 h-index

    5 publications

    105 citations

  6. Esteve (Spain)

    Barcelona, Spain

    2 h-index

    18 publications

    657 citations

  7. Esteve Química (Spain)

    Barcelona, Spain

    2 h-index

    18 publications

    657 citations

  8. Harvard University

    Cambridge, United States

    2 h-index

    4 publications

    162 citations

1–8 of 157

Venues

  1. PubMed

    Repository · 2 publications · 30 citations

    2

    h-index

  2. Journal of Clinical Oncology

    2 publications · 125 citations

    2

    h-index

  3. British Journal of Clinical Pharmacology

    BJCP · 2 publications · 73 citations

    2

    h-index

  4. Current Medical Research and Opinion

    CMRO · 2 publications · 52 citations

    2

    h-index

  5. Neuro-Oncology

    1 publications · 228 citations

    1

    h-index

1–5